Orchard Therapeutics plc (ORTX)

Instructure Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	23.47	68.42	55.91	55.14	19.05	335.84
Short-Term Investments	101.94	75.33	164.2	136.81	305.94	-
Cash & Short-Term Investments	125.41	143.75	220.11	191.95	324.99	335.84
Cash Growth	-14.42%	-34.69%	14.67%	-40.94%	-3.23%	273.76%
Accounts Receivable	6.19	8.47	1.48	0.88	1.44	2.1
Other Receivables	10.79	8.87	35.24	22.14	19.54	10.59
Receivables	16.97	17.34	36.72	23.02	20.99	12.69
Inventory	6.64	3.4	2.02	0.67	-	-
Prepaid Expenses	4	2.7	8.57	6.35	3.92	6.99
Other Current Assets	0.9	0.96	7.91	1.55	-	-
Total Current Assets	153.92	168.15	275.32	223.54	349.9	355.52
Property, Plant & Equipment	27.13	30.91	29.08	34.6	27.01	5.48
Other Intangible Assets	3.32	3.56	4.15	3.08	-	-
Long-Term Deferred Tax Assets	-	7.37	4.09	5.22	2.99	-
Long-Term Deferred Charges	-	0.46	0.69	0.98	0.31	-
Other Long-Term Assets	17.89	8.46	9.08	13.54	19.08	5.05
Total Assets	202.27	218.91	322.41	280.94	399.28	366.04
Accounts Payable	3.66	9.32	10.01	8.82	11.98	18.13
Accrued Expenses	30	30.67	21.59	25.78	34.99	24.06
Current Portion of Long-Term Debt	9.43	9.43	0.79	4.86	-	-
Current Portion of Leases	5.55	6.42	7.34	8.93	5.89	-
Current Unearned Revenue	0.74	0.96	0.35	-	-	-
Other Current Liabilities	-	3.77	2.73	3.17	2.99	5.72
Total Current Liabilities	49.38	60.57	42.79	51.56	55.86	47.91
Long-Term Debt	16.16	22.99	32.09	20.2	24.7	-
Long-Term Leases	16.68	19.25	19.28	24.17	15.32	-
Long-Term Unearned Revenue	10.35	10.32	12.52	-	-	-
Other Long-Term Liabilities	29.45	7.52	5.78	6.57	4.21	6.8
Total Liabilities	122.01	120.64	112.46	102.5	100.09	54.7
Common Stock	29.46	16.42	16.25	12.51	12.33	10.92
Additional Paid-In Capital	994.11	956.71	940.68	771.19	738.48	587.49
Retained Earnings	-965.92	-900.88	-750.22	-605.64	-453.66	-290.24
Comprehensive Income & Other	22.61	26.02	3.25	0.37	2.04	3.16
Total Common Equity	80.26	98.26	209.95	178.43	299.19	311.34
Shareholders' Equity	80.26	98.26	209.95	178.43	299.19	311.34
Total Liabilities & Equity	202.27	218.91	322.41	280.94	399.28	366.04
Total Debt	47.82	58.09	59.49	58.17	45.91	-
Net Cash (Debt)	77.59	85.66	160.62	133.78	279.08	335.84
Net Cash Growth	-11.93%	-46.67%	20.06%	-52.06%	-16.90%	273.76%
Net Cash Per Share	4.51	6.69	12.96	13.45	29.93	148.87
Filing Date Shares Outstanding	22.76	18.4	12.58	12.37	9.71	8.59
Total Common Shares Outstanding	22.73	13.02	12.57	9.83	9.69	8.59
Working Capital	104.55	107.58	232.53	171.97	294.04	307.61
Book Value Per Share	3.53	7.55	16.71	18.16	30.87	36.26
Tangible Book Value	76.94	94.7	205.8	175.36	299.19	311.34
Tangible Book Value Per Share	3.39	7.28	16.38	17.84	30.87	36.26
Machinery	-	9.1	8.26	6.18	7.07	5.24
Construction In Progress	-	0.76	0.21	0.3	1.85	0.24
Leasehold Improvements	-	5.07	2.45	2.52	1.84	1.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q